Xeureka

  • HOME
  • COMPANY
    • ABOUT US
    • OUR TEAM
  • TECHNOLOGY
    • Target Analysis
    • Ultra Large Scale Virtual Screening
    • Free Energy Perturbation (FEP)
    • AI & Simulation for Drug Design
  • SERVICE
  • NEWS
  • BLOG
  • CAREER
  • CONTACT

Ultra Large Primary Screening

July 12, 2022

一覧へ戻る
INNOVATOR OF DRUG DISCOVERY THROUGH CONVERGENCE OF DRY & WET

COMPANY

  • About us
  • Our Team

SERVICE

CAREER

TECHNOLOGY

  • Target Analysis
  • Ultra Large Scale Virtual Screening
  • AI & Simulation for Drug Design
  • Free Energy Perturbation（FEP）

NEWS

BLOG

CONTACT

Xeureka Inc.
Toranomon 30 Mori Building 9F
3-2-2 Toranomon
Minato-ku, Tokyo 105-0001, Japan

© Xeureka Inc.

  • HOME

  • COMPANY

    • About us
    • Our Team

  • SERVICE

  • CAREER

  • TECHNOLOGY

    • Target Analysis
    • Ultra Large Scale Virtual Screening
    • AI & Simulation for Drug Design
    • Free Energy Perturbation（FEP）

  • NEWS

  • BLOG

  • CONTACT

  • EN
  • JP